BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Peking University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Trishula Therapeutics, Inc.
Hummingbird Bioscience
Mayo Clinic
Taiho Pharmaceutical Co., Ltd.
OHSU Knight Cancer Institute
Seagen Inc.
AstraZeneca
Altor BioScience
Barts & The London NHS Trust
SCRI Development Innovations, LLC
Incyte Corporation
University of California, San Francisco